NCT01971255 Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People Status COMPLETED Phase PHASE1/PHASE2
NCT01967784 Study of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in Taiwan Status COMPLETED Phase PHASE3
NCT01959945 Safety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Formulation) Status COMPLETED Phase PHASE3
NCT01949090 Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older Status COMPLETED Phase PHASE2
NCT01946438 Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adults Status COMPLETED Phase PHASE4
NCT01946425 Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine Status COMPLETED Phase PHASE4
NCT01945424 Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry Status COMPLETED Phase N/A
NCT01938352 Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge Status COMPLETED Phase PHASE2
NCT01934127 Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age Status COMPLETED Phase PHASE1
NCT01916759 Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda Status COMPLETED Phase NA
NCT01906593 A Post-marketing Safety Study of Beijing Tiantan Biological's Influenza Virus Vaccine in Elderly Status COMPLETED Phase N/A
NCT01893177 Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains (2013-14) Status COMPLETED Phase PHASE3